Differential Runx3, Eomes, and T‐bet expression subdivides MS‐associated CD4+ T cells with brain‐homing capacity
Open Access
- 7 December 2023
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 54 (2) , e2350544
Abstract
Multiple sclerosis (MS) is a common and devastating chronic inflammatory disease of the CNS. CD4+ T cells are assumed to be the first to cross the blood–central nervous system (CNS) barrier and trigger local inflammation. Here, we explored how pathogenicity‐associated effector programs define CD4+ T cell subsets with brain‐homing ability in MS. Runx3‐ and Eomes‐, but not T‐bet‐expressing CD4+ memory cells were diminished in the blood of MS patients. This decline reversed following natalizumab treatment and was supported by a Runx3+Eomes+T‐bet− enrichment in cerebrospinal fluid samples of treatment‐naïve MS patients. This transcription factor profile was associated with high granzyme K (GZMK) and CCR5 levels and was most prominent in Th17.1 cells (CCR6+CXCR3+CCR4−/dim). Previously published CD28− CD4 T cells were characterized by a Runx3+Eomes−T‐bet+ phenotype that coincided with intermediate CCR5 and a higher granzyme B (GZMB) and perforin expression, indicating the presence of two separate subsets. Under steady‐state conditions, granzyme Khigh Th17.1 cells spontaneously passed the blood–brain barrier in vitro. This was only found for other subsets including CD28− cells when using inflamed barriers. Altogether, CD4+ T cells contain small fractions with separate pathogenic features, of which Th17.1 seems to breach the blood–brain barrier as a possible early event in MS.Keywords
This publication has 69 references indexed in Scilit:
- CD4+NKG2D+ T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in NeuroinflammationPLOS ONE, 2013
- Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple SclerosisThe Journal of Immunology, 2013
- The discovery of natalizumab, a potent therapeutic for multiple sclerosisJournal of Cell Biology, 2012
- Human Th17 subsetsEuropean Journal of Immunology, 2012
- CX3CR1 drives cytotoxic CD4+CD28− T cells into the brain of multiple sclerosis patientsJournal of Autoimmunity, 2012
- Cutting Edge: Loss of α4 Integrin Expression Differentially Affects the Homing of Th1 and Th17 CellsThe Journal of Immunology, 2011
- Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLsJournal of Experimental Medicine, 2009
- The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cellsBrain, 2008
- Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammationNature Medicine, 2007
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammationJournal of Experimental Medicine, 2005